HealthLynked Reports First Quarter 2019 Financial Results and Recent Revenue Improvement

NEXT STORY
BeyondSpring’s Rationale for the Plinabulin-Neulasta Combination for Neutropenia Prevention Accepted as Abstracts at 2019 ASCO Annual Meeting
PREV STORY
Résultats positifs de la plateforme ciblée en oncologie de Theratechnologies présentés en ligne à ASCO
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Research Antibodies and Reagents Market Worth $6.32 billion by 2027, Growing at a CAGR of 5.6% From 2020, Says Meticulous Research®

author_avatar
NASDAQ Market News

Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

author_avatar
NASDAQ Market News